Balanced news tone
News Sentiment
RMD sentiment intelligence
ResMed Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
52
Balanced news tone
58 relevant articles
News tone and price action are not far from neutral.
82/100 classification confidence.
directly relevant articles
high-authority source matches
-2.7% over one week, +4.7% over four weeks, trend inactive, and near fair-value range.
ResMed Inc. stock rises Wednesday, outperforms market
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
82/100 classification
One-week reaction
-2.7%
Price reacting lower
Trend fit
Trend inactive
4.7% over four weeks
Fair value
-6.1%
Near fair-value range
Sentiment Mix
Positive, neutral, negative
Positive
15
Neutral
33
Negative
10
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
Ad Hoc News
Direct company coverage
ResMed Inc. focuses on sleep and respiratory care. Long-term demand supports the business model.
- Tone
- Neutral 50/100
- Event
- Macro sensitivity
- Published
- 08 Jul 2026 16:36
- Source
- Ad Hoc News
Market source
Direct company coverage
ResMed (RMD) Soars 4.2%: Is Further Upside Left in the Stock?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 07 Jul 2026 07:00
- Source
- Market source
Reuters
Direct company coverage
ResMed to sell software business MatrixCare for $490 million
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 07 Jul 2026 07:00
- Source
- Reuters
Moomoo
Direct company coverage
Why Resmed (RMD) Stock Is Up Today
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Jul 2026 07:00
- Source
- Moomoo
simplywall.st
Direct company coverage
ResMed Stock And 2 Blue Chip Picks Retail Investors May Be Missing
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Jul 2026 07:00
- Source
- simplywall.st
Market source
Direct company coverage
Why ResMed (RMD) Stock Is Trading Up Today
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jul 2026 07:00
- Source
- Market source
Ad Hoc News
Direct company coverage
ResMed Inc. focuses on sleep and respiratory care as a long-term growth story
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 01 Jul 2026 16:39
- Source
- Ad Hoc News
Market source
Direct company coverage
ResMed (RMD) Stock Looks Cheap Even As The Market Stays Cautious
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Jul 2026 07:00
- Source
- Market source
simplywall.st
Direct company coverage
ResMed (RMD) Stock Looks Reasonable After A 23% Fall
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 01 Jul 2026 07:00
- Source
- simplywall.st
Market source
Direct company coverage
Is ResMed Inc. (RMD) Stock Still a Long-Term Winner as OSA Market Expansion Continues?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 25 Jun 2026 07:00
- Source
- Market source
thebull.com.au
Direct company coverage
ResMed Shares Downgraded: Trimmed Price Target Offers Some Comfort To Bulls
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 18 Jun 2026 07:00
- Source
- thebull.com.au
Market source
Direct company coverage
Why ResMed (RMD) Shares Are Falling Today
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jun 2026 07:00
- Source
- Market source
Market source
Direct company coverage
ResMed (RMD) Stock Valuation Check After Mixed Returns And Undervaluation Signals
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Jun 2026 07:00
- Source
- Market source
Market source
Direct company coverage
Is ResMed Inc. (RMD) A Good Stock To Buy Now?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 11 Jun 2026 07:00
- Source
- Market source
Market source
Direct company coverage
Is It Time To Reassess ResMed (RMD) After A 25% Share Price Slide?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Jun 2026 07:00
- Source
- Market source
Ad Hoc News
Direct company coverage
ResMed Inc stock (AU000000RMD6): ex-dividend date approaches May 14
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 May 2026 07:00
- Source
- Ad Hoc News
Kalkine
Direct company coverage
ResMed (ASX:RMD) Q3 Results 2026: Is the ASX Healthcare Stock Back on Track?
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 12 May 2026 07:00
- Source
- Kalkine
Ad Hoc News
Direct company coverage
ResMed Inc stock (AU000000RMD6): Sleep apnea and respiratory care leader posts strong growth outlook
- Tone
- Positive 82/100
- Event
- Guidance
- Published
- 10 May 2026 07:00
- Source
- Ad Hoc News
TIKR.com
Direct company coverage
ResMed Stock Is Down 22% in 2026: Here’s Why Analysts Still Sees $256 Fair Value
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 May 2026 07:00
- Source
- TIKR.com
Market source
Direct company coverage
ResMed (RMD) Surpasses Q3 Earnings and Revenue Estimates
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 30 Apr 2026 07:00
- Source
- Market source
TradingView
Direct company coverage
Resmed's Q3 Earnings on Deck: What's in Store for the Stock?
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 23 Apr 2026 07:00
- Source
- TradingView
Market source
Direct company coverage
ResMed (RMD) Stock Trades Down, Here Is Why
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 Mar 2026 07:00
- Source
- Market source
ig.com
Direct company coverage
Stock of the day: ResMed
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Jan 2026 08:00
- Source
- ig.com
TradingView
Direct company coverage
Resmed's Q2 Earnings on Deck: What's in Store for the Stock?
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 27 Jan 2026 08:00
- Source
- TradingView
simplywall.st
Direct company coverage
ResMed Inc. (NYSE:RMD) is favoured by institutional owners who hold 69% of the company
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jan 2026 08:00
- Source
- simplywall.st
ig.com
Direct company coverage
ASX 200 healthcare stocks: ResMed, CSL, and Telix Pharmaceuticals in focus
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Sep 2025 07:00
- Source
- ig.com
TradingView
Direct company coverage
RESMED INC SEC 10-K Report
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Aug 2025 07:00
- Source
- TradingView
simplywall.st
Direct company coverage
ResMed Full Year 2025 Earnings: EPS Beats Expectations
- Tone
- Positive 85/100
- Event
- Earnings
- Published
- 03 Aug 2025 07:00
- Source
- simplywall.st